Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey Liu

Showing results (1-10 of 574) with videos related to

Pageof 58
Sort By:
Connecticut Medicine|September 9, 2014
Two wordsGeoffrey Liu
Healthcarepapers|May 1, 2012
Can routine collection of patient reported outcome data actually improve person-centered health?Doris Howell, Geoffrey Liu
Journal of Medical Imaging and Radiation Oncology|February 26, 2021
Malignant priapism in metastatic adenocarcinoma of gastrointestinal origin: A <sup>18</sup> F-FDG PET/CT studyGeoffrey Liu, Mihir Patel
The Oncologist|July 8, 2009
Studying genetic variations in cancer prognosis (and risk): a primer for cliniciansSevtap Savas, Geoffrey Liu
Journal of Medical Imaging and Radiation Oncology|December 7, 2020
A case of omental torsion and infarct diagnosed on computed tomographyGeoffrey Liu, Mihir Patel
Human Mutation|July 30, 2009
Genetic variations as cancer prognostic markers: review and updateSevtap Savas, Geoffrey Liu
Advanced Drug Delivery Reviews|December 23, 2008
Pharmacokinetics and pharmacogenomics in breast cancer chemotherapySharon Marsh, Geoffrey Liu
Pharmacogenomics|October 4, 2013
VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 updateLawson Eng, Geoffrey Liu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2023
Re: Response to Letter to the Editor "Respiratory and Cardiometabolic Comorbidities and Stage I-III Non-Small Cell Lung Cancer (NSCLC) Survival: A Pooled Analysis From the International Lung Cancer Consortium"Miguel García-Pardo, Geoffrey Liu
Advances in Therapy|August 12, 2023
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain MetastasisGeoffrey Liu, Vincent K Lam
Pageof 58

Showing results (1-10 of 574) with videos related to

Sort By:
Pageof 58
Connecticut Medicine|September 9, 2014
Two wordsGeoffrey Liu
Healthcarepapers|May 1, 2012
Can routine collection of patient reported outcome data actually improve person-centered health?Doris Howell, Geoffrey Liu
Journal of Medical Imaging and Radiation Oncology|February 26, 2021
Malignant priapism in metastatic adenocarcinoma of gastrointestinal origin: A <sup>18</sup> F-FDG PET/CT studyGeoffrey Liu, Mihir Patel
The Oncologist|July 8, 2009
Studying genetic variations in cancer prognosis (and risk): a primer for cliniciansSevtap Savas, Geoffrey Liu
Journal of Medical Imaging and Radiation Oncology|December 7, 2020
A case of omental torsion and infarct diagnosed on computed tomographyGeoffrey Liu, Mihir Patel
Human Mutation|July 30, 2009
Genetic variations as cancer prognostic markers: review and updateSevtap Savas, Geoffrey Liu
Advanced Drug Delivery Reviews|December 23, 2008
Pharmacokinetics and pharmacogenomics in breast cancer chemotherapySharon Marsh, Geoffrey Liu
Pharmacogenomics|October 4, 2013
VEGF pathway polymorphisms as prognostic and pharmacogenetic factors in cancer: a 2013 updateLawson Eng, Geoffrey Liu
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 20, 2023
Re: Response to Letter to the Editor "Respiratory and Cardiometabolic Comorbidities and Stage I-III Non-Small Cell Lung Cancer (NSCLC) Survival: A Pooled Analysis From the International Lung Cancer Consortium"Miguel García-Pardo, Geoffrey Liu
Advances in Therapy|August 12, 2023
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain MetastasisGeoffrey Liu, Vincent K Lam
Pageof 58